Sven Johan Magnus Kjellberg
Chief Executive Officer chez Nextmune AB
Fortune : 11 M $ au 31/03/2024
Profil
Sven Johan Magnus Kjellberg is currently the Co-President and CEO of Nextmune AB.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIMIAN GROUP AB
0,44% | 31/12/2022 | 2 213 257 ( 0,44% ) | 7 M $ | 31/03/2024 |
VIMIAN GROUP AB
9,29% | 31/12/2022 | 1 367 912 ( 9,29% ) | 4 M $ | 31/03/2024 |
Postes actifs de Sven Johan Magnus Kjellberg
| Sociétés | Poste | Début |
|---|---|---|
Nextmune AB
 Nextmune AB Pharmaceuticals: MajorHealth Technology Nextmune AB operates as a specialty pharmaceutical company which engages in companion-animal allergy testing and treatment. It offers skin treatment for dog, cat, horse, food and allergy testing services. The company was founded in 2016 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Nextmune AB
Nextmune AB Pharmaceuticals: MajorHealth Technology Nextmune AB operates as a specialty pharmaceutical company which engages in companion-animal allergy testing and treatment. It offers skin treatment for dog, cat, horse, food and allergy testing services. The company was founded in 2016 and is headquartered in Stockholm, Sweden. | Health Technology |
